Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05330429
Title Study of Magrolimab Given Together With FOLFIRI/BEV in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Gilead Sciences

colorectal cancer

colorectal adenocarcinoma


Bevacizumab + Fluorouracil + Irinotecan + Leucovorin

Bevacizumab + Fluorouracil + Hu5F9-G4 + Irinotecan + Leucovorin

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST